Aeon Metals Limited News - AMLN

Critical Alerts for Hartford Financial Services, Apple, Yamana Gold, Amylin Pharmaceuticals and MetLife Released by Seven Summit

CHICAGO, Jan. 13 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for HIG, AAPL, AUY, AMLN and MET. Seven Summits Strategic...

Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference

SAN DIEGO, Nov. 5, 2009 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) will be presenting at the 18th Annual Credit Suisse...

Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity

SAN DIEGO and OSAKA, Japan, Nov. 1, 2009 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) and Takeda Pharmaceutical Company...

BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes

Prescribing Information Also Includes Updated Safety Information SAN DIEGO and INDIANAPOLIS, Oct. 30, 2009 /PRNewswire-FirstCall/ -- Amylin...

UPDATE: Roche's New Diabetes Drug Works Better Than Byetta

Roche Holding AG (ROG.VX) said Thursday its experimental diabetes drug taspoglutide worked better than a rival drug sold by Eli Lilly & Co...

Roche: New Diabetes Drug Works Better Than Byetta - Study

Roche Holding AG (ROG.VX) said Thursday its experimental diabetes drug taspoglutide worked better than a rival drug sold by Eli Lilly & Co...

Amylin Pharmaceuticals to Present at the 4th Annual BIOCOM Investor Conference

SAN DIEGO, CA, Oct. 22, 2009 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) will be presenting at the 4th Annual BIOCOM...

2ND UPDATE:Galleon Holdings Include OSI Pharma,Huron Consulting

The stocks of a few small companies could be unintended victims of Galleon Group's problems. Galleon, the hedge-fund manager whose founder, Raj...

UPDATE: Galleon Holdings Include OSI Pharma, Huron Consulting

The stocks of a few small companies could be unintended victims of Galleon Group's problems. Galleon, the hedge-fund manager whose founder, Raj...

Galleon Holdings Include OSI Pharmaceuticals, Huron Consulting

The stocks of a few small companies could be unintended victims of Galleon Group's problems. Galleon, the hedge-fund manager whose founder, Raj...

Novo Nordisk's Diabetes Drug Victoza Successful In Study

Danish pharmaceutical company Novo Nordisk A/S (NOVO-B.KO) said Wednesday its drug Victoza has been shown in a clinical study to be more efficient...

Amylin Pharmaceuticals Board of Directors Elects Paulo F. Costa Chairman of the Board

SAN DIEGO, Aug. 24 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) today announced that its Board of Directors has elected...

Novo Nordisk CEO: Positive Victoza Reception In Europe

Novo Nordisk A/S's (NOVO-B.KO) diabetes treatment Victoza has had a positive reception since it was launched on a number of European markets in...

Amylin 2Q Loss Narrows On Cost-Cutting; Byetta Sales Slip

Amylin Pharmaceuticals Inc.'s (AMLN) second-quarter loss narrowed as the company's cost-cutting efforts were able to offset a drop in revenue...

Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study

Significant Reductions in Weight and Fewer Reports of Hypoglycemia Compared to Lantus Also Observed SAN DIEGO, INDIANAPOLIS and CAMBRIDGE, Mass...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Aeon Metals Limited (AMLN)

Empower your portfolio: Real-time discussions and actionable trading ideas.

AMLN News

Critical Alerts for Hartford Financial Services, Apple, Yamana Gold, Amylin Pharmaceuticals and MetLife Released by Seven Summit

Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference

Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity

BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes

UPDATE: Roche's New Diabetes Drug Works Better Than Byetta

Roche: New Diabetes Drug Works Better Than Byetta - Study

Amylin Pharmaceuticals to Present at the 4th Annual BIOCOM Investor Conference

2ND UPDATE:Galleon Holdings Include OSI Pharma,Huron Consulting

UPDATE: Galleon Holdings Include OSI Pharma, Huron Consulting

Galleon Holdings Include OSI Pharmaceuticals, Huron Consulting

Novo Nordisk's Diabetes Drug Victoza Successful In Study

Amylin Pharmaceuticals Board of Directors Elects Paulo F. Costa Chairman of the Board

Novo Nordisk CEO: Positive Victoza Reception In Europe

Amylin 2Q Loss Narrows On Cost-Cutting; Byetta Sales Slip

Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study

AMLN Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Aeon Metals Limited (AMLN) News

Aeon Metals Limited (AMLN)

Empower your portfolio: Real-time discussions and actionable trading ideas.

AMLN News

Critical Alerts for Hartford Financial Services, Apple, Yamana Gold, Amylin Pharmaceuticals and MetLife Released by Seven Summit

Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference

Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity

BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes

UPDATE: Roche's New Diabetes Drug Works Better Than Byetta

Roche: New Diabetes Drug Works Better Than Byetta - Study

Amylin Pharmaceuticals to Present at the 4th Annual BIOCOM Investor Conference

2ND UPDATE:Galleon Holdings Include OSI Pharma,Huron Consulting

UPDATE: Galleon Holdings Include OSI Pharma, Huron Consulting

Galleon Holdings Include OSI Pharmaceuticals, Huron Consulting

Novo Nordisk's Diabetes Drug Victoza Successful In Study

Amylin Pharmaceuticals Board of Directors Elects Paulo F. Costa Chairman of the Board

Novo Nordisk CEO: Positive Victoza Reception In Europe

Amylin 2Q Loss Narrows On Cost-Cutting; Byetta Sales Slip

Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study

AMLN Discussion

Your Recent History